B

Bionano Genomics
D

BNGO

4.04000
USD
0.04
(1.00%)
مغلق
حجم التداول
823
الربح لكل سهم
-11
العائد الربحي
-
P/E
-0
حجم السوق
12,148,280
أصول ذات صلة
C
CRSP
0.520
(1.38%)
38.220 USD
E
EDIT
0.01500
(0.93%)
1.63000 USD
F
FATE
0.09000
(7.38%)
1.31000 USD
M
MCRB
0.16000
(1.68%)
9.66000 USD
N
NTLA
0.20000
(2.32%)
8.83000 USD
P
PACB
0.03000
(2.71%)
1.13500 USD
PSTG
PSTG
1.355
(2.92%)
47.835 USD
R
RGEN
4.530
(3.30%)
141.720 USD
T
TDOC
0.09000
(1.29%)
7.06500 USD
V
VCEL
1.025
(2.70%)
38.935 USD
المزيد
الأخبار المقالات

العنوان: Bionano Genomics Inc

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, ofwhich the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.